| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.76M | - | |
| COO | 160.7K | $8.33M | - | |
| CFO | 104.4K | $5.41M | - | |
| Other | 76.0K | $3.94M | - | |
| VP | 29.0K | $1.50M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 2,616 | $73.70 | $192,799.23 | -0.3% | -2.1% | +1.8% | |
| Feb 26, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 45,000 | $78.09 | $3,514,106.06 | -2.3% | -13.0% | +0.5% | |
| Feb 20, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $74.53 | $596,231.64 | -3.2% | +2.5% | +12.5% | |
| Feb 1, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $73.87 | $123,143.91 | -1.9% | -15.6% | +16.9% | |
| Feb 1, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 3,000 | $73.88 | $221,626.16 | -0.4% | -15.6% | +16.9% | |
| Jan 31, 2024 | Lukatch Heath | Director | Sale+OE | 5,000 | $71.50 | $357,500.00 | -47.1% | -15.2% | +28.7% | |
| Jan 29, 2024 | Lukatch Heath | Director | Sale+OE | 4,000 | $67.50 | $270,000.00 | -41.6% | -10.9% | +34.5% | |
| Jan 29, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 30,000 | $66.03 | $1,980,900.00 | -7.4% | -10.9% | +34.5% | |
| Jan 23, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $63.92 | $958,782.94 | -1.3% | -5.4% | +33.1% | |
| Jan 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $60.73 | $485,878.64 | -2.4% | +2.6% | +40.2% |